License agreements - Innovent (Details) - Innovent $ in Millions |
1 Months Ended | 12 Months Ended | ||
---|---|---|---|---|
Jun. 30, 2019
USD ($)
|
Jan. 31, 2019
USD ($)
|
Dec. 31, 2018
USD ($)
item
|
Dec. 31, 2019
USD ($)
|
|
License agreements | ||||
Upfront and immediate milestone payment to be received under license agreement | $ 40.0 | |||
Research and development expenses reimbursed | $ 6.2 | |||
Reimbursable costs included in accounts receivable | $ 3.0 | |||
Product candidates | item | 3 | |||
Regulatory Milestones | ||||
License agreements | ||||
Milestone payment made under license agreement | $ 20.0 | |||
Regulatory Milestones | Maximum | ||||
License agreements | ||||
Upfront and immediate milestone payment to be received under license agreement | $ 20.0 | |||
Development and Regulatory Milestones | Maximum | ||||
License agreements | ||||
Upfront and immediate milestone payment to be received under license agreement | 129.0 | |||
Commercialization Milestones | Maximum | ||||
License agreements | ||||
Upfront and immediate milestone payment to be received under license agreement | $ 202.5 |